Omeros | Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Adma Biologics USD 61.38M 28.9M 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Cytokinetics USD 225.47M 150.53M 2025-09
Dynavax Technologies USD 160.25M 61.15M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Immunic USD 35.13M 20.18M 2025-09
Insmed USD 334.76M 949.56M 2025-09
Knight Therapeutics CAD 77.82M 34.34M 2025-06
MacroGenics USD 80.13M 50.56M 2025-09
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 147.59M 152.89M 2025-09
Pfizer USD 1.34B 295M 2025-09
Rockwell Medical USD 12.48M 1.09M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
United Therapeutics USD 1.34B 253M 2025-09
Vertex Pharmaceuticals USD 6.29B 95.8M 2025-09
Xoma USD 143.9M 7.68M 2024-06


Omeros Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.